Intermittent Fasting for Women: The Evidence

Does Intermittent Fasting Affect Women Differently Than Men?

Direct sex-comparative trials are scarce; most evidence comes from separate studies in women and in men rather than head-to-head comparisons. Reviews describe women as potentially more sensitive to energy restriction's effects on reproductive and neuroendocrine signaling, particularly under low energy availability, but call the evidence limited and context-dependent (Fraile-Martínez et al., 2026 [8]; La Vignera and Condorelli, 2026) [9]. The same review also notes that women and men share several beneficial responses to intermittent fasting, including improvements in body composition and cardiometabolic markers (Fraile-Martínez et al., 2026) [8].

La Vignera and Condorelli's review states that direct measurements of female sexual-function domains are "largely absent from the literature," and attributes the limited evidence quality to small samples, heterogeneous fasting protocols, short follow-up, and a reliance on animal data in parts of the field (La Vignera and Condorelli, 2026) [9]. A separate narrative review focused on the menopausal transition reads the recent data more favorably than the trials below: its abstract states that early concerns about reproductive and endocrine disturbance have given way to data suggesting beneficial effects in both sexes, with the favorable findings in women concentrated in PCOS and in postmenopausal women who combined fasting with physical activity. It is a narrative review without new trial data, and those two bodies of evidence are the ones this page treats separately below (Drinnon et al., 2026) [10]. Where a specific trial exists for a question below, this page cites that trial directly rather than relying on the general framing in these reviews.

Does Intermittent Fasting Change Hormones in Women?

In the longest randomized trial cited here, which enrolled adults with obesity rather than a PCOS population, 12 months of time-restricted eating did not change testosterone, DHEA, or sex hormone-binding globulin in premenopausal or postmenopausal women with obesity, or estradiol, estrone, or progesterone in postmenopausal women, compared with calorie restriction or no intervention (Lin et al., 2024) [1].

That null result matches the pattern in the available systematic review: of 6 studies reviewed, the randomized trials in women with general obesity found no significant change in testosterone, estrogen, progesterone, LH, cortisol, DHEA, or SHBG from time-restricted eating. The studies that did report favorable hormone changes were non-randomized studies in women with PCOS, and the review's own authors say those changes may have been confounded by weight loss (Jirapak et al., 2026) [6]. PCOS is a diagnosed condition, and research conducted in people with it is not evidence for women without it; this page does not cite the PCOS-specific trials behind that review's favorable PCOS finding as evidence for women in general. An earlier, smaller review of the trials available at the time described lower androgen markers and higher SHBG in premenopausal women with obesity from intermittent fasting, with no change in estrogen, gonadotropins, or prolactin, but stated directly that very few studies existed and called its own findings preliminary (Cienfuegos et al., 2022) [7].

Taken together, the randomized evidence in women with general obesity does not show a hormone benefit from intermittent fasting, and the systematic review itself calls the overall evidence inconclusive and limited to six studies (Jirapak et al., 2026) [6]. That is a different statement from "unproven but promising": the longest single trial cited here found no change at all, and the systematic review's randomized evidence agrees.

Does Intermittent Fasting Affect the Menstrual Cycle?

No randomized trial measuring menstrual cycle regularity or length as an outcome in women without PCOS was found in this search. The hormone trials above measured blood hormone levels, not cycle outcomes directly, and PCOS-specific research is excluded here as a separate, disease-focused body of evidence.

A null hormone result is not the same finding as "no effect on your cycle," since the two trials above measured hormone levels at set points, not cycle regularity or length. This is a genuine gap in the published research, not a reassurance this page can offer in its place. Anyone tracking changes to their own cycle after starting intermittent fasting, or anyone trying to conceive, should talk to a clinician rather than rely on this page's absence of a finding either way.

Does Intermittent Fasting Affect Bone Health in Women?

A 6-month randomized trial found no change in bone mineral density, bone mineral content, or bone turnover markers from alternate-day fasting compared with calorie restriction or no intervention, with no difference between premenopausal and postmenopausal women in the sub-analysis (Barnosky et al., 2017) [2].

The trial randomized 100 adults with overweight or obesity to alternate-day fasting, daily calorie restriction, or no intervention for 6 months. Lean mass, total-body bone mineral content and density, and the bone markers osteocalcin, bone alkaline phosphatase, and CTX were unchanged across all three groups; IGF-1 rose in the calorie-restriction group only. See alternate-day fasting for how alternate-day fasting, the schedule used in this trial, compares with daily calorie restriction on weight, cholesterol, and dropout.

Is Intermittent Fasting Different for Women Going Through Menopause?

A handful of small trials combining time-restricted eating with exercise, and in one case added protein, found improvements in menopausal symptoms, quality of life, or muscle strength in menopausal women, but none isolates fasting's own effect from exercise or protein, all are small, and the two that report a duration ran 8 and 12 weeks (Jóźwiak et al., 2025 [5]; Valenzano et al., 2025 [3]; Yang et al., 2026) [4].

A quasi-randomized trial of 54 menopausal women, with allocation partly by participant preference rather than full randomization, a limitation of the design, compared 16:8 time-restricted eating plus exercise against exercise alone. The combination group (n=24) showed a greater reduction than the exercise-only group (n=30) in total, psychological, and somatic Menopause Rating Scale domains (p=0.008, 0.009, 0.007), and in the physical and psychosocial domains of a separate quality-of-life scale, with no difference in urogenital, vasomotor, or sexual domains (Jóźwiak et al., 2025) [5]. A pilot trial of 30 postmenopausal women over 8 weeks compared intermittent fasting plus high-intensity interval training against a low-calorie diet plus the same training, with both arms exercising and no non-exercising control; flexibility and VO2 max improved overall (6% and 10%), and the abstract reports a large effect size on endurance for the low-calorie-diet arm (Cohen's d -0.90), not for the fasting arm; the authors call for further research (Valenzano et al., 2025) [3]. A three-arm trial of 96 postmenopausal women over 12 weeks compared Nordic walking plus high-protein intake plus time-restricted eating, Nordic walking plus time-restricted eating without added protein, and a control group, with no time-restricted-eating-only arm in the design; handgrip strength improved in both intervention arms and most in the protein-added arm, while the time-restricted-eating-plus-walking arm without added protein showed less favorable changes in lean-mass measures, which the abstract does not quantify; the authors state the results should be read as differences between intervention packages, not as the effect of any single component (Yang et al., 2026) [4].

In each of these trials, the result belongs to the combined intervention, exercise, protein, or both, together with time-restricted eating, not to fasting on its own. A separate 4-week pilot trial of 43 healthy adult women, not a menopausal population, using 16:8 time-restricted eating alone without an exercise component, found a BMI reduction versus control and no significant difference in working memory or attentional control (McLeod et al., 2026); see 16:8 intermittent fasting for that trial in full.

Is Intermittent Fasting Safe During Pregnancy or Breastfeeding?

No randomized trial of intermittent fasting during pregnancy or lactation was found, and no study of a non-religious fasting schedule in either situation. The human research that exists is observational and concerns Ramadan fasting, a daytime fast without food or water that is not the schedule this site describes; it is outside this page's scope, and the animal studies found cannot support a human safety claim either way. The only guidance this page gives is to talk to a clinician before fasting of any kind while pregnant, trying to conceive, or breastfeeding.

The animal studies found in this search are not described here, because findings in rats do not translate into a human safety or benefit claim in either direction. For a reader in this situation, the relevant fact is that no randomized human trial exists to draw on, not what was found in animals.

Who Should Talk to a Clinician Before Trying Intermittent Fasting as a Woman?

Talk to a clinician before trying intermittent fasting of any kind if you are pregnant, breastfeeding, or trying to conceive; under 18; have a history of disordered eating; or manage diabetes with medication.

These are reasons to get individual guidance before starting, not after. For pregnancy, breastfeeding, and trying to conceive, the reason is that no randomized human trial exists either way, as described above. For a history of disordered eating, being under 18, or diabetes managed with medication, the reason is that the risks of restricting food intake depend on your history and your medication, and need a clinician who knows both. See how to start intermittent fasting for the sitewide version of this guidance and for schedule selection generally; this section expands it for the gaps specific to this page.

Authors and Funding of the Cited Studies

• Lin et al., 2024 [1]: Krista A. Varady is senior and corresponding author. The paper's competing-interests statement: "K.A.V. received author fees from Pan MacMillan for the book, The Fastest Diet. The other authors declare no conflicts of interest."
• Barnosky et al., 2017 [2]: Krista A. Varady is senior author. The paper's conflict-of-interest statement: "Krista Varady is the author of the book, 'The Every Other Day Diet'. The other authors have no competing interests." Funding: National Institutes of Health (NHLBI R01HL106228 and T32HL007034; NIDDK F32DK107157).
• Valenzano et al., 2025 [3]: authors declare no conflicts of interest.
• Yang et al., 2026 [4]: authors declare no conflicts of interest.
• Jóźwiak et al., 2025 [5]: authors declare no conflicts of interest.
• Jirapak et al., 2026 [6]: no conflict-of-interest statement is present in the PubMed record, and the publisher's full text could not be retrieved for this page.
• Cienfuegos et al., 2022 [7]: Krista A. Varady is senior author. Conflict-of-interest statement: "The authors declare no conflict of interest."
• Fraile-Martínez et al., 2026 [8]: authors declare no conflicts of interest.
• La Vignera and Condorelli, 2026 [9]: authors declare no conflicts of interest.
• Drinnon et al., 2026 [10]: authors declare no conflicts of interest.
• Disclosures are listed where the full text of the paper was available to us; a study not listed here is not a statement that its authors have no ties.

Safety and Cautions

This is general information, not medical advice. The trials on this page are small, short, or narrow in what they measured, and several of the most relevant questions, including effects on the menstrual cycle and on fasting during pregnancy or breastfeeding, have no randomized human trial at all. Talk to a clinician before fasting of any kind if you are pregnant, breastfeeding, or trying to conceive; under 18; have a history of disordered eating; or manage diabetes with medication. Stop and seek care for any severe or concerning symptom.

Related Reading

For how alternate-day fasting, the schedule used in the bone-metabolism trial above, compares with daily calorie restriction on weight and other outcomes, see alternate-day fasting. For the 16:8 pilot trial in women cited above, see 16:8 intermittent fasting. For schedule selection and the sitewide clinician-guidance caution, see how to start intermittent fasting.